GB Sciences, Inc. (GBLX)
0.0002
0.00 (0.00%)
USD |
OTCM |
Sep 17, 16:00
GB Sciences Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | -0.1243M |
| September 30, 2024 | -0.1077M |
| June 30, 2024 | -0.022M |
| March 31, 2024 | -0.2525M |
| December 31, 2023 | -0.2054M |
| September 30, 2023 | -0.4125M |
| June 30, 2023 | -0.1053M |
| March 31, 2023 | -0.2199M |
| December 31, 2022 | -0.3994M |
| September 30, 2022 | -0.6155M |
| June 30, 2022 | -0.292M |
| March 31, 2022 | -0.6652M |
| December 31, 2021 | -0.4285M |
| September 30, 2021 | -0.1359M |
| June 30, 2021 | -0.6366M |
| March 31, 2021 | -0.932M |
| December 31, 2020 | -1.040M |
| September 30, 2020 | 0.111M |
| June 30, 2020 | -0.3238M |
| March 31, 2020 | -0.2314M |
| December 31, 2019 | -2.46M |
| September 30, 2019 | 0.8428M |
| June 30, 2019 | -2.631M |
| March 31, 2019 | -2.008M |
| December 31, 2018 | -1.464M |
| Date | Value |
|---|---|
| September 30, 2018 | -2.888M |
| June 30, 2018 | -3.496M |
| March 31, 2018 | -4.226M |
| December 31, 2017 | -2.771M |
| September 30, 2017 | -3.061M |
| June 30, 2017 | -2.190M |
| March 31, 2017 | -1.628M |
| December 31, 2016 | -1.148M |
| September 30, 2016 | -0.7354M |
| June 30, 2016 | -0.9579M |
| March 31, 2016 | -0.7019M |
| December 31, 2015 | -1.296M |
| September 30, 2015 | -0.4789M |
| June 30, 2015 | -1.087M |
| March 31, 2015 | -0.2308M |
| December 31, 2014 | -0.8695M |
| September 30, 2014 | -1.507M |
| June 30, 2014 | -0.9388M |
| March 31, 2014 | -0.1803M |
| December 31, 2013 | -0.005M |
| September 30, 2013 | -0.0175M |
| June 30, 2013 | -0.0109M |
| March 31, 2013 | -0.0011M |
| December 31, 2012 | -0.0112M |
| September 30, 2012 | -0.023M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -2.536M |
| CNBX Pharmaceuticals, Inc. | -0.0477M |
| Arvinas, Inc. | -48.30M |
| Fulcrum Therapeutics, Inc. | -16.04M |
| Definium Therapeutics, Inc. | -52.33M |